- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04740762
The Effect of Individual Counselling Program on Fear of Childbirth
The Effectiveness of an Individual Counselling Program in Coping With Fear of Childbirth: A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Fear of childbirth is a common problem among women and one that affects their health and welfare before and during pregnancy and in the postpartum period. The problem can lead to adverse pregnancy outcomes and also cause a woman to experience psychological issues. Fear of childbirth can also influence the determination of the mode of delivery and can amount to a rise in cesarean rates.
The healthcare provided by midwives and other healthcare professionals during pregnancy and childbirth have the power to reduce or exacerbate childbirth fears. The most significant midwifery intervention that can be used to diminish the fear of childbirth is counseling. There is a need to develop and test individual counseling models that require the basic training skills that midwives can use as part of their routine care to address women's fears and expectations about childbirth. The individual counseling program developed in this context may be an easy-to-implement and cost-effective method to use.
This study was conducted for the purposes of developing an individual counseling program to help women cope with their fear of childbirth and testing the program for effectiveness.
It was tested the hypotheses that there is no difference between the intervention and control groups of pregnant women after the intervention in terms of fear of childbirth, childbirth self-efficacy and state anxiety scores and childbirth outcomes (duration of labor, mode of delivery, elective and emergency cesarean rates, postpartum hypertension and need for a blood transfusion, the admittance of the newborn into the intensive care unit, preferences for future births and duration of stay in hospital).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Efeler
-
Aydın, Efeler, Turkey, 09100
- Turkey
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Primiparas
- Ages between 18-35
- Lived in Aydın
- In gestational week 28-30,
- Pregnant with a single child
- Minimum a primary school graduate (since the questionnaires would be filled out by self-reporting)
- In a low-risk pregnancy (on the basis of the criteria of the Ministry of Health),
- Willing to divulge their own or their husband's telephone numbers,
Exclusion Criteria:
- High-risk pregnancy who had psychological and mental health problems
- History of infertility
- Speech and hearing disabilities
- Substance or narcotics users
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
The control group continued to receive the routine care
|
|
Experimental: Intervention group
The study group were provided with individual counseling program and followed in this study, in addition to the usual care provided by healthcare professionals.
|
The women in the intervention groups were administered a three-session intervention program in addition to the routine care they received.The program encompassed providing the women with an educational booklet, childbirth stories and childbirth videos that were created to reduce their fears of childbirth.The interviews were held a total of three times, in gestational weeks 28-30, 31-33 and 34-36.
The duration of the intervention at each visit was 60-80 minutes.
Depending on the woman's own preference, she was invited to visit the delivery room at the second or last session and meet the midwives there.
The women who did not wish to go to the delivery room were alternatively provided with photographs of the delivery room so they could take a look.
Again as part of the education program, the women were given the links to the selected childbirth videos and given the opportunity to watch them.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fear of childbirth before intervention
Time Frame: 28-30 gestational weeks
|
assessed using the Wijma Delivery Expectancy/Experience Questionnaire- Version A. This instrument contains questions on women's prenatal expectations to measure the nature of the fear experienced during and following childbirth.
The instrument makes it possible to identify the nature of the fear of childbirth women feel before their delivery.
This scale contain 33 questions.
Wijma Delivery Expectancy/Experience Questionnaire- Version A is based on a 6-point Likert scale numbered 0-5.
Zero corresponds to the response, "Totally" and five means "none."
The minimum possible score on the scale is a "0"; maximum is 165.
Higher scores indicate greater levels of Fear of Childbirth.
|
28-30 gestational weeks
|
Fear of childbirth after intervention
Time Frame: 36-38 gestational weeks
|
assessed using the Wijma Delivery Expectancy/Experience Questionnaire- Version A. This instrument contains questions on women's prenatal expectations to measure the nature of the fear experienced during and following childbirth.
The instrument makes it possible to identify the nature of the fear of childbirth women feel before their delivery.
This scale contain 33 questions.
Wijma Delivery Expectancy/Experience Questionnaire- Version A is based on a 6-point Likert scale numbered 0-5.
Zero corresponds to the response, "Totally" and five means "none."
The minimum possible score on the scale is a "0"; maximum is 165.
Higher scores indicate greater levels of Fear of Childbirth.
|
36-38 gestational weeks
|
Fear of childbirth after birth
Time Frame: 12th-24th hour after the birth
|
assessed using the Wijma Delivery Expectancy/Experience Questionnaire- Version B. This instrument contains questions on women's postpartum experiences to measure the nature of the fear experienced during and following childbirth.
The instrument makes it possible to identify the nature of the fear of childbirth women feel after their delivery.
This scale contain 33 questions.
Wijma Delivery Expectancy/Experience Questionnaire- Version-B is based on a 6-point Likert scale where the responses are numbered from 1-6 and one corresponds to the response, "Totally" and six means "none."
The total possible score on the scale varies between 33-198.
Higher scores indicate greater levels of Fear of Childbirth.
|
12th-24th hour after the birth
|
Childbirth Self-Efficacy before intervention
Time Frame: 28-30 gestational weeks
|
assessed using the Childbirth Self-efficacy Inventory-Short Form.
The instrument measure levels of self-efficacy during labor.
The scale is comprised of two subscales-outcome expectancies and self-efficacy expectancies.
In the outcome expectancies subscale, responses range from 1: "not at all helpful" to 10: "very helpful," while in the self-efficacy expectancies subscale, the first 13 items are marked as 1: "Completely sure," to 10: "Not at all sure" and items 14-16 receive a score of 1: "Not at all sure" to 10: "Completely sure."
All the responses to the inventory are based on a 10-point Likert-type scale.
The lowest possible score on the Childbirth Self-efficacy Inventory is 32; the highest is 320.
The higher the score, the more self-efficacy and confidence the pregnant woman has.
|
28-30 gestational weeks
|
Childbirth Self-Efficacy after intervention
Time Frame: 36-38 gestational weeks
|
assessed using the Childbirth Self-efficacy Inventory-Short Form.
The instrument measure levels of self-efficacy during labor.
The scale is comprised of two subscales-outcome expectancies and self-efficacy expectancies.
In the outcome expectancies subscale, responses range from 1: "not at all helpful" to 10: "very helpful," while in the self-efficacy expectancies subscale, the first 13 items are marked as 1: "Completely sure," to 10: "Not at all sure" and items 14-16 receive a score of 1: "Not at all sure" to 10: "Completely sure."
All the responses to the inventory are based on a 10-point Likert-type scale.
The lowest possible score on the Childbirth Self-efficacy Inventory is 32; the highest is 320.
The higher the score, the more self-efficacy and confidence the pregnant woman has.
|
36-38 gestational weeks
|
State Anxiety before intervention
Time Frame: 28-30 gestational weeks
|
assessed using the State Anxiety Inventory.
The instrument is composed of 20 items.
The total possible score on the instrument varies between 20-80.
The measurements according to the State Anxiety Inventory scores indicate no anxiety at a score of 0-19, moderate anxiety at 20-39, a high level of anxiety at 40-59, severe anxiety at 60-79 and panic-evoking anxiety at 80 and above.
|
28-30 gestational weeks
|
State Anxiety after intervention
Time Frame: 36-38 gestational weeks
|
assessed using the Childbirth Self-efficacy Inventory-Short Form.
The instrument measure levels of self-efficacy during labor.
The scale is comprised of two subscales-outcome expectancies and self-efficacy expectancies.
In the outcome expectancies subscale, responses range from 1: "not at all helpful" to 10: "very helpful," while in the self-efficacy expectancies subscale, the first 13 items are marked as 1: "Completely sure," to 10: "Not at all sure" and items 14-16 receive a score of 1: "Not at all sure" to 10: "Completely sure."
All the responses to the inventory are based on a 10-point Likert-type scale.
The lowest possible score on the Childbirth Self-efficacy Inventory is 32; the highest is 320.
The higher the score, the more self-efficacy and confidence the pregnant woman has.
|
36-38 gestational weeks
|
Duration of labor
Time Frame: 12th-24th hour after the birth
|
used to determine the duration of labor.
Duration of labor was recorded by the researcher to postpartum questionnaire as hours from hospital record.
|
12th-24th hour after the birth
|
Mode of Delivery
Time Frame: 12th-24th hour after the birth
|
used to determine the mode of delivery.
Mode of delivery was recorded by the researcher to the postpartum questionnaire as vaginal or cesarean section.
|
12th-24th hour after the birth
|
Elective and Emergency Cesarean Rates
Time Frame: 12th-24th hour after the birth
|
used to determine the elective and emergency cesarean rates.
Elective and emergency cesarean rates were recorded by the researcher to postpartum questionnaires as yes or no from hospital record.
|
12th-24th hour after the birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postpartum hypertension
Time Frame: 12th-24th hour after the birth
|
used to determine postpartum hypertension.
Postpartum hypertension was recorded by the researcher to postpartum questionnaires as yes or no from hospital record.
|
12th-24th hour after the birth
|
Need for a blood transfusion
Time Frame: 12th-24th hour after the birth
|
used to determine needing for a blood transfusion.
Needing for a blood transfusion was recorded by the researcher from hospital record to postpartum questionnaires as yes or no depending on whether there was a blood transfusion.
|
12th-24th hour after the birth
|
Admittance of the Newborn into the Intensive Care Unit
Time Frame: 12th-24th hour after the birth
|
used to determine the admittance of the newborn into the intensive care unit.
Admittance of the Newborn into the Intensive Care Unit was recorded by the researcher from hospital records to postpartum questionnaires as yes or no depending on whether the baby was in intensive care.
|
12th-24th hour after the birth
|
Preferences for Future Births
Time Frame: 12th-24th hour after the birth
|
used to determine the preferences for future births.
Preferences for future births was measured and recorded by the researcher to postpartum questionnaires as vaginal or cesarean section.
|
12th-24th hour after the birth
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Gizem Öztürk, PhD, Adnan Menderes University, Faculty of Health Sciences, Division of Midwifery
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- interventional study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Clinical Study Report (CSR)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy Related
-
Helen Keller InternationalEleanor Crook FoundationNot yet recruitingPregnancy Related | Supplementation | Postnatal Related
-
4YouandMeCambridge Cognition Ltd; Sema4; Evidation Health; Vector Institute of Artificial... and other collaboratorsCompletedPregnancy Related | Wearables | Pregnancy EarlyUnited States
-
The University of Texas Health Science Center,...CompletedPregnancy Related | Pregnancy, High RiskUnited States
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Shaare Zedek Medical CenterUnknownPregnancy Related | Pregnancy, High Risk | Anesthesia
-
University of CopenhagenStanford UniversityRecruitingPregnancy RelatedDenmark
-
European Vaccine InitiativeKintampo Health Research Centre, Ghana; Groupe de Recherche Action en Sante; Fondation... and other collaboratorsRecruitingPregnancy RelatedBenin, Burkina Faso, Ghana, Malawi
-
Kahramanmaras Sutcu Imam UniversityNot yet recruitingPregnancy RelatedTurkey
-
Fondation Hôpital Saint-JosephRecruiting
-
German Institute of Human NutritionRecruiting
Clinical Trials on Intervention group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Vitalija StonkuvienėRecruitingFrailty SyndromeLithuania